BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 18024613)

  • 1. Hemoglobin e syndromes.
    Vichinsky E
    Hematology Am Soc Hematol Educ Program; 2007; ():79-83. PubMed ID: 18024613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thalassemia.
    Cohen AR; Galanello R; Pennell DJ; Cunningham MJ; Vichinsky E
    Hematology Am Soc Hematol Educ Program; 2004; ():14-34. PubMed ID: 15561674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability of hemoglobin F expression in hemoglobin EE disease: hematological and molecular analysis.
    Pakdee N; Yamsri S; Fucharoen G; Sanchaisuriya K; Pissard S; Fucharoen S
    Blood Cells Mol Dis; 2014; 53(1-2):11-5. PubMed ID: 24581976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron overload and iron-chelating therapy in hemoglobin E-beta thalassemia.
    Olivieri NF; De Silva S; Premawardena A; Sharma S; Viens AM; Taylor CM; Brittenham GM; Weatherall DJ
    J Pediatr Hematol Oncol; 2000; 22(6):593-7. PubMed ID: 11132236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential diagnosis of adult hemoglobin A, F, and S conditions. A case of G gamma-beta(+)-hereditary persistence of fetal hemoglobin.
    Carter DK; Lucia MS; Winter SD
    Arch Pathol Lab Med; 1991 May; 115(5):533-6. PubMed ID: 1708658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrum of hemoglobinopathies in the state of Orissa, India: a ten years cohort study.
    Balgir RS
    J Assoc Physicians India; 2005 Dec; 53():1021-6. PubMed ID: 16572956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of thalassemia in southeast Asia.
    Winichagoon P; Fucharoen S; Wilairat P; Fukumaki Y
    Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():235-40. PubMed ID: 8629113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implication of globin gene expression, hemoglobin F and hemoglobin E levels on β-thalassemia/Hb E disease severity.
    Siriworadechkul S; Jindadamrongwech S; Chuncharunee S; Aupparakkitanon S
    Ann Clin Lab Sci; 2014; 44(4):437-42. PubMed ID: 25361929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microcytic hypochromic anemia: should high performance liquid chromatography be used routinely for screening anemic and antenatal patients?
    Philip J; Sarkar RS; Kushwaha N
    Indian J Pathol Microbiol; 2013; 56(2):109-13. PubMed ID: 24056645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Rapamycin as Inducer of Hb F in Primary Erythroid Cultures from Sickle Cell Disease and β-Thalassemia Patients.
    Pecoraro A; Troia A; Calzolari R; Scazzone C; Rigano P; Martorana A; Sacco M; Maggio A; Di Marzo R
    Hemoglobin; 2015; 39(4):225-9. PubMed ID: 26016899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Homozygous hemoglobin-E (Hb-EE) disease].
    Amendola G; Danise P; Di Palma A; Franzese M; Avino D; D'Arco AM
    Pediatr Med Chir; 2004; 26(1):65-7. PubMed ID: 15529816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing patterns of thalassemia worldwide.
    Vichinsky EP
    Ann N Y Acad Sci; 2005; 1054():18-24. PubMed ID: 16339647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advantages in the use of high performance liquid chromatography technique for screening hemoglobinopathies in Venezuela].
    Bravo-Urquiola M; Arends A; Montilla S; Velásquez D; Garcìa G; Alvarez M; Guevara J; Castillo O
    Invest Clin; 2004 Dec; 45(4):309-15. PubMed ID: 15602897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromatographic measurements of hemoglobin A2 in blood samples that contain sickle hemoglobin.
    Shokrani M; Terrell F; Turner EA; Aguinaga MD
    Ann Clin Lab Sci; 2000 Apr; 30(2):191-4. PubMed ID: 10807164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and Molecular Characteristics of Non-Transfusion-Dependent Thalassemia in Kuwait.
    Adekile AD; Azab AF; Al-Sharida SI; Al-Nafisi BA; Akbulut N; Marouf RA; Mustafa NY
    Hemoglobin; 2015; 39(5):320-6. PubMed ID: 26076396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hemoglobin E syndromes.
    Rees DC; Styles L; Vichinsky EP; Clegg JB; Weatherall DJ
    Ann N Y Acad Sci; 1998 Jun; 850():334-43. PubMed ID: 9668555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homozygosity for the severe β(+)-thalassemia mutation [IVS-I-5 (G>C)] causes the phenotype of thalassemia trait: an extremely rare presentation.
    Bohara V; Raut L; Badarkhe G; Roy SS; Chaudhuri U
    Hemoglobin; 2013; 37(1):101-5. PubMed ID: 23234478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart failure in beta-thalassemia syndromes: a decade of progress.
    Hahalis G; Alexopoulos D; Kremastinos DT; Zoumbos NC
    Am J Med; 2005 Sep; 118(9):957-67. PubMed ID: 16164878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of coinherited Hb H-Constant Spring/Paksé disease and Hb E by capillary electrophoresis and high performance liquid chromatography.
    Pornprasert S; Waneesorn J
    Hemoglobin; 2013; 37(2):176-82. PubMed ID: 23234508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxyurea for hemoglobin E/β-thalassemia: a systematic review and meta-analysis.
    Algiraigri AH; Kassam A
    Int J Hematol; 2017 Dec; 106(6):748-756. PubMed ID: 28786080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.